Bausch + Lomb Corporation announced the appointment of Eduardo C. Alfonso, MD, and Steven H. Collis to its board of directors effective January 1, 2026.
The board will now be comprised of 10 directors following changes announced in August 2025.
Both appointees bring significant expertise and experience to help shape the company's future.
Appointment of Eduardo C. Alfonso, MD
Internationally recognized expert in corneal and external eye diseases, serving as director of the Bascom Palmer Eye Institute.
Appointment of Steven H. Collis
Known for his leadership at Cencora, Inc., a major pharmaceutical distribution and healthcare services company.
Board Expansion
The appointments expand the Bausch + Lomb board to 10 directors, enhancing diversity and expertise.
- The addition of Dr. Alfonso and Mr. Collis will bring valuable perspectives to the board, aiding in strategic decision-making and growth initiatives.
- Their combined experience in ophthalmology, pharmaceuticals, and corporate leadership will strengthen the company's position in the eye health market.
The new board appointments signal Bausch + Lomb's commitment to enhancing its governance and leadership team, poised for future growth and innovation in eye health.